insights_auto
Zakaj je tečaj 524494 padel 3,51%?
Podrobneje raziščichevron_right
524494:BOM
IPCA Laboratories Ltd
1.845,00 ₹
arrow_downward
−3,51%(−67,20) 1D
16. okt., 15:30:00 GMT +5.30 · INR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za 524494 …
Odpri
1.913,95 ₹
Visoka
1.913,95 ₹
Nizka
1.812,60 ₹
Tržna kapitalizacija
468,21 mrd.
Povprečni promet
27,90 tis.
Promet
12,00 tis.
Dividenda
0,33 %
Četrtletna dividenda
1,50 ₹
Prvi trgovalni dan brez upravičenja do dividende
7. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
35,74
52-tedenski najvišji tečaj
2.039,30 ₹
52-tedenski najnižji tečaj
1.252,95 ₹
Čisti dobiček na delnico
51,63 ₹
Št. izdanih delnic
126,35 mio.
Št. zaposlenih
17 tis.
Odpri
1.913,95 ₹
Visoka
1.913,95 ₹
Nizka
1.812,60 ₹
Tržna kapitalizacija
468,21 mrd.
Povprečni promet
27,90 tis.
Promet
12,00 tis.
Dividenda
0,33 %
Četrtletna dividenda
1,50 ₹
Prvi trgovalni dan brez upravičenja do dividende
7. avg. 2026
Razmerje med ceno delnice in čistim dobičkom
35,74
52-tedenski najvišji tečaj
2.039,30 ₹
52-tedenski najnižji tečaj
1.252,95 ₹
Čisti dobiček na delnico
51,63 ₹
Št. izdanih delnic
126,35 mio.
Št. zaposlenih
17 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
ACROFAN USA
·
pred 18 minutami
BCRF Launches $100 Million Venture Program for Breast Cancer: NYSE Content Update
The Daily News | Texas' Oldest Newspaper
·
pred 38 minutami
Traders work on the floor of the NYSE in New York
The National Law Review
·
pred 9 minutami
Kaplan Fox Continues to Remind Honeywell Aerospace Inc. (NASDAQ
The Motley Fool
·
pred 45 minutami
S&P 500 Stock Casey's Dropped 30% in Its Biggest Pullback Since the Great Recession -- Here's Why I'm Buying More
Profil
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
Vizitka: IPCA Laboratories Ltd
Generalni direktor-
Št. zaposlenih17,2 tis.
Ustanovljeno19. okt. 1949
Sedež-
Sektor-
Spletno mestoipca.com